Lucy Gregory

Lucy Gregory is a Consultant Health Economist at Hardian Health, where she specialises in health economics and outcomes research, focusing on the adoption and implementation of AI as a medical device. She holds a MSc in International Health Policy (Health Economics) from The London School of Economics. Lucy’s interest in the intersection of health policy and economics drives her work in developing appropriate methods to be used to create value assessments and health technology evaluations that guide decision-makers in adopting AI in healthcare.

Lucy has worked on the health economic assessments of digital therapeutics diagnostics and pharmaceutical interventions across a range of therapy areas. These include radiology, neurology, gastroenterology, oncology, paediatrics and infectious disease. She has also health economic modeller on several government-funded research grants generating evidence to support industry reimbursement efforts.

Hardian Health is a healthcare consultancy that offers support to businesses of all sizes, innovators, universities and technology developers. Their multidisciplinary team provides expert support for medical devices including regulation, clinical validation, market strategy, health economic modelling and intellectual property support, with a particular focus on software as a medical device (SaMD). Hardian has a strong track record of successfully supporting companies through their journey to market, bridging the gap between innovation and healthcare systems, ensuring that new medical technologies are adopted efficiently and sustainably, benefiting both patients and providers.